Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Summary

Hepatitis A vaccine is the most frequently used traveler's vaccine, yet data on its ability to induce protective immunity in immunosuppressed travelers are scarce. The investigators assess the hepatitis A virus (HAV) antibody response in patients with rheumatoid arthritis (RA) treated with Tumor Necrosis Factor (TNF) - inhibitors and/or methotrexate (Mtx). In a previous study, 2 doses were not considered effective and there is therefore need for a study with an additional dose

Timeline

Start

2011-09

Primary completion

2016-08

Completion

2016-08

Drugs

Indications

No indication recorded.